Post by ITM Isotope Technologies Munich SE

At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Los Angeles, California, we connected with leading minds from across the global #NuclearMedicine community and exchanged perspectives on the latest developments shaping the #Radiopharmaceutical field. Once again, SNMMI proved to be a valuable place to bring together science, clinical practice, and industry with a shared goal of advancing patient care. Building on these valuable exchanges, we thank everyone who visited our booth and contributed to the discussions, especially Dr. Julia Fricke from Universitätsspital Basel (USB). As part of our Dinner Symposium, Dr. Fricke shared her perspective on the evolution of SSTR targeted therapy. She continued the dialogue during Meet the Experts sessions at our booth. If you missed her presentations, a recording of the symposium is available on the SNMMI website: https://lnkd.in/dX75tgec Beyond the scientific program, we were also proud to participate in SNMMI’s Patient Education Day, bringing together patients, advocates, healthcare professionals, and industry representatives to foster dialogue and strengthen patient-centered care. 👇 Below are some of our highlights from this year’s meeting. #SNMMI2026